Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study

Affiliations

• ¹ Department of Neurology, University of Miami, 1120 NW 14th Street, Clinical Research Building, Room 1318, Miami, FL, 33136, USA. mbenatar@med.miami.edu.
• ² Department of Neurology, University of Miami, 1120 NW 14th Street, Clinical Research Building, Room 1318, Miami, FL, 33136, USA.
• ³ Department of Clinical Science, Neurosciences, Umeå University, Umeå, Sweden.
• ⁴ Washington University School of Medicine, St. Louis, MO, USA.
• ⁵ The Neurological Institute, Columbia University Irving Medical Center, New York, NY, USA.
• ⁶ Department of Neurology, Martin Luther University, Halle-Wittenberg, Halle (Saale), Germany.
• ⁷ Duke University School of Law, Durham, NC, USA.
• ⁸ Columbia University Irving Medical Center, New York, NY, USA.
• ⁹ Biogen, 225 Binney Street, Cambridge, MA, 02142, USA.
• ¹⁰ Biogen, 225 Binney Street, Cambridge, MA, 02142, USA. Stephanie.fradette@biogen.com.